Skip to content
10-K

Annual Report

CALYPTE BIOMEDICAL CORP

0001437749-12-002667

← back to feed
Filed
Mar 22, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Mar 22, 2012 700.17M sh
Shares Diluted FY 2011 · Dec 31, 2011 545.85M sh
Shares Diluted FY 2011 · Dec 31, 2010 487.62M sh
Capex FY 2011 · Dec 31, 2011 $5K
Capex FY 2011 · Dec 31, 2010 $36K
Operating Cash Flow FY 2011 · Dec 31, 2010 −$682K
Current Liabilities FY 2011 · Dec 31, 2010 $3.89M
Total Liabilities FY 2011 · Dec 31, 2010 $7.43M
Current Assets FY 2011 · Dec 31, 2010 $403K
Total Assets FY 2011 · Dec 31, 2010 $2.33M
Sga Expense FY 2011 · Dec 31, 2010 $999K
Rd Expense FY 2011 · Dec 31, 2010 $282K
Net Income FY 2011 · Dec 31, 2010 $8.84M
Operating Income FY 2011 · Dec 31, 2010 −$1.1M
Cost Of Revenue FY 2011 · Dec 31, 2010 $260K
Cash And Equivalents FY 2011 · Dec 31, 2009 $160K
Stockholders Equity FY 2011 · Dec 31, 2009 −$14.67M